Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: C01CA24

Eurneffy(epinephrine)

Anaphylaxis

Marketing Authorisation Holder: ALK-Abelló A/S

EMA Authorisation: 22/08/2024

INN: epinephrine

Indication

Eurneffy is indicated in the emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products and other allergens as well as idiopathic or exercise induced anaphylaxis. Treatment is indicated for adults and children aged 4 years and over with a body weight of 15 kg or more.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Eurneffy — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.